SALOMONI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 1.506
EU - Europa 552
AS - Asia 165
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.227
Nazione #
US - Stati Uniti d'America 1.504
GB - Regno Unito 272
SE - Svezia 76
CN - Cina 60
IT - Italia 52
SG - Singapore 52
DE - Germania 50
UA - Ucraina 39
HK - Hong Kong 26
FI - Finlandia 24
TR - Turchia 21
BG - Bulgaria 15
FR - Francia 15
IN - India 5
IE - Irlanda 3
CA - Canada 2
NL - Olanda 2
RU - Federazione Russa 2
BE - Belgio 1
EG - Egitto 1
EU - Europa 1
ID - Indonesia 1
LT - Lituania 1
NZ - Nuova Zelanda 1
ZA - Sudafrica 1
Totale 2.227
Città #
Southend 243
Fairfield 213
Woodbridge 203
Chandler 103
Ashburn 93
Jacksonville 88
Houston 83
Seattle 79
Santa Clara 77
Ann Arbor 68
Dearborn 68
Cambridge 67
Nyköping 61
Wilmington 59
Singapore 45
Hong Kong 26
San Diego 26
Modena 21
Princeton 18
Des Moines 16
Beijing 15
Eugene 15
Sofia 15
New York 12
Izmir 11
Helsinki 10
London 7
Shanghai 7
Buffalo 6
San Jose 6
Guangzhou 5
Norwalk 5
Redwood City 5
Boardman 4
Frankfurt am Main 4
Paris 4
Andria 3
Chicago 3
Dongguan 3
Dublin 3
Hefei 3
Occhiobello 3
San Mateo 3
Albuquerque 2
Bremen 2
Chiswick 2
Delhi 2
Detroit 2
Gelsenkirchen 2
Hounslow 2
Kunming 2
Leawood 2
Livorno 2
Milan 2
Milwaukee 2
Mountain View 2
Munich 2
Pescara 2
Romainville 2
Rome 2
Saint Petersburg 2
Shenyang 2
Wuhan 2
Amsterdam 1
Bangalore 1
Berlin 1
Brussels 1
Cairo 1
Chongqing 1
Columbus 1
Fremont 1
Genoa 1
Groningen 1
Gunzenhausen 1
Hanover 1
Hebei 1
Jakarta 1
Jinan 1
Las Vegas 1
Linyi 1
Nanchang 1
Nanjing 1
Ottawa 1
San Francisco 1
Toronto 1
Tulare 1
Verona 1
Washington 1
Wuxi 1
Zhengzhou 1
Totale 1.876
Nome #
Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: implications for the pathogenesis of the disease 202
Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells. 201
Suppression of autophagy by BCR/ABL 165
Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors 163
The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing. 162
Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. 159
D-ribose and deoxy-D-ribose induce apoptosis in human quiescent peripheral blood mononuclear cells. 158
Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of bcl-2 expression and Myb-dependent regulation of bcl-2 promoter activity 152
Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis. 152
Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant 146
Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2 128
Bcl-2 expression restores the leukemogenic potential of a BCR/ABL mutant defective in transformation. 119
Targeting BCR-ABL-independent TKI resistance in chronic myeloid leukemia by mTOR and autophagy inhibition 117
Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction 109
Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt. 107
Totale 2.240
Categoria #
all - tutte 9.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.214


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020336 0 0 0 0 48 71 73 43 41 17 17 26
2020/2021353 21 16 16 30 58 13 24 56 14 63 26 16
2021/2022271 15 24 40 12 16 10 17 16 26 19 48 28
2022/2023321 33 45 20 27 31 59 3 35 44 1 16 7
2023/2024142 5 10 9 11 25 34 9 13 7 3 6 10
2024/2025139 15 0 3 43 78 0 0 0 0 0 0 0
Totale 2.240